Advertisement

HealthStream, Inc. HSTM

Set alert

Price alert · HSTM

All alert types
33.70 USD -0.10 -0.30%

At close · Oct 30

33.70 0.00 0.00%

After hours · Oct 30, 4:33 PM ET

Bid
33.65 × 2
Ask
33.70 × 2
33.17 Day range 34.04
19.88 52-week range 35.16
YTD
+46.08%
1 year
+37.27%
Open
33.86
Prev close
33.80
Mkt cap
1.03B
Vol
151.63K
Avg vol
195.55K
EPS
0.72
P/E
46.81
Div yield
0.40%
More statistics
Low
33.17
High
34.04
Forward P/E
38.06
Beta
0.42
Short ratio
6.52
Inst. own
76.85%
Dividend
0.14
Ex-div date
Aug 16, 2026
Earnings
Nov 2, 2026
50-d avg
30.84
200-d avg
25.52
1y target
35.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 4, 2024Dividend: 0.028
  • Mar 10, 2025Dividend: 0.031
  • May 15, 2025Rating: Canaccord Genuity · Hold → Hold
  • May 19, 2025Dividend: 0.031
  • Aug 4, 2025Earnings: 0.18; estimate 0.16; surprise 12.5%
  • Aug 7, 2025Rating: Canaccord Genuity · Hold → Hold
  • Aug 18, 2025Dividend: 0.031
  • Nov 3, 2025Earnings: 0.2; estimate 0.17; surprise 17.65%
  • Nov 17, 2025Dividend: 0.031
  • Dec 17, 2025Rating: Canaccord Genuity · Hold → Hold
  • Feb 23, 2026Earnings: 0.09; estimate 0.16; surprise -43.75%
  • Mar 9, 2026Dividend: 0.035
  • May 4, 2026Earnings: 0.2; estimate 0.16; surprise 25%
  • May 6, 2026Rating: Canaccord Genuity · Hold → Hold
  • May 18, 2026Dividend: 0.035
  • Jul 21, 2026Rating: Canaccord Genuity · Hold → Hold
  • Aug 3, 2026Earnings: 0.23; estimate 0.166; surprise 38.55%
  • Aug 17, 2026Dividend: 0.035
  • Oct 13, 2026Rating: Freedom Capital Markets · — → Hold
Signals (86)
NameDateAgo
MACD: Sell SignalOct 28, 20263 days ago
RSI: OverboughtOct 5, 20263 weeks ago
MACD: Buy SignalSep 30, 20261 month ago
MACD: Sell SignalSep 8, 20261 month ago
MACD: Buy SignalSep 1, 20262 months ago
MACD: Sell SignalAug 31, 20262 months ago
MACD: Buy SignalAug 28, 20262 months ago
MACD: Sell SignalAug 5, 20262 months ago
MACD: Buy SignalAug 4, 20262 months ago
MACD: Sell SignalJul 15, 20263 months ago
RSI: OverboughtJul 1, 20264 months ago
MACD: Buy SignalJun 30, 20264 months ago
MACD: Sell SignalJun 16, 20264 months ago
SMA: BullishMay 26, 20265 months ago
SMA: BullishMay 19, 20265 months ago
SMA: BearishMay 6, 20265 months ago
SMA: BullishMay 5, 20265 months ago
MACD: Buy SignalMay 5, 20265 months ago
RSI: OverboughtMay 5, 20265 months ago
SMA: BullishMay 4, 20266 months ago
MACD: Sell SignalMay 1, 20266 months ago
SMA: BearishApr 30, 20266 months ago
SMA: BullishApr 24, 20266 months ago
SMA: BearishApr 23, 20266 months ago
SMA: BullishApr 15, 20266 months ago
MACD: Buy SignalApr 15, 20266 months ago
MACD: Sell SignalApr 1, 20267 months ago
SMA: BearishMar 31, 20267 months ago
SMA: BullishMar 25, 20267 months ago
MACD: Buy SignalMar 25, 20267 months ago
MACD: Sell SignalMar 12, 20267 months ago
SMA: BearishMar 10, 20267 months ago
SMA: BullishMar 4, 20268 months ago
SMA: BearishFeb 25, 20268 months ago
SMA: BullishFeb 24, 20268 months ago
MACD: Buy SignalFeb 18, 20268 months ago
MACD: Sell SignalFeb 4, 20268 months ago
RSI: OversoldFeb 4, 20268 months ago
MACD: Buy SignalJan 27, 20269 months ago
RSI: OversoldJan 23, 20269 months ago
RSI: OversoldJan 20, 20269 months ago
RSI: OversoldJan 8, 20269 months ago
RSI: OversoldJan 2, 202610 months ago
MACD: Sell SignalDec 26, 202510 months ago
MACD: Buy SignalDec 23, 202510 months ago
MACD: Sell SignalDec 8, 202510 months ago
MACD: Buy SignalNov 19, 202511 months ago
MACD: Sell SignalNov 6, 202511 months ago
MACD: Buy SignalNov 5, 202512 months ago
RSI: OversoldOct 29, 20251 year ago
MACD: Sell SignalOct 28, 20251 year ago
MACD: Buy SignalOct 22, 20251 year ago
RSI: OversoldOct 10, 20251 year ago
SMA: BearishOct 1, 20251 year ago
MACD: Sell SignalSep 24, 20251 year ago
RSI: OverboughtSep 11, 20251 year ago
SMA: BullishAug 21, 20251 year ago
MACD: Buy SignalAug 12, 20251 year ago
MACD: Sell SignalJul 30, 20251 year ago
MACD: Buy SignalJul 23, 20251 year ago
MACD: Sell SignalJul 18, 20251 year ago
MACD: Buy SignalJul 16, 20251 year ago
MACD: Sell SignalJul 15, 20251 year ago
MACD: Buy SignalJun 26, 20251 year ago
MACD: Sell SignalJun 25, 20251 year ago
MACD: Buy SignalJun 23, 20251 year ago
MACD: Sell SignalJun 20, 20251 year ago
MACD: Buy SignalMay 27, 20251 year ago
SMA: BearishMay 6, 20251 year ago
MACD: Sell SignalMay 6, 20251 year ago
RSI: OversoldMay 6, 20251 year ago
SMA: BullishApr 23, 20251 year ago
SMA: BearishApr 17, 20251 year ago
SMA: BullishApr 15, 20251 year ago
MACD: Buy SignalApr 11, 20251 year ago
MACD: Sell SignalApr 7, 20251 year ago
MACD: Buy SignalMar 25, 20251 year ago
SMA: BearishMar 10, 20251 year ago
SMA: BullishFeb 26, 20251 year ago
SMA: BearishFeb 24, 20251 year ago
MACD: Sell SignalFeb 21, 20251 year ago
SMA: BullishJan 23, 20251 year ago
MACD: Buy SignalJan 21, 20251 year ago
MACD: Sell SignalJan 10, 20251 year ago
MACD: Buy SignalJan 8, 20251 year ago
RSI: OverboughtNov 25, 20241 year ago

Key statistics

Market cap
1.03B
Enterprise value
935.01M
Trailing P/E
46.78
Forward P/E
38.06
PEG ratio
3.31
Price / sales
3.21
Price / book
2.76
EPS (TTM)
0.72
Beta
0.42
Dividend yield
0.40%
Payout ratio
18.33%
Profit margin
6.60%
Revenue (TTM)
321.12M
Revenue growth
12.50%
Free cash flow
50.33M
Total cash
66.73M
Total debt
13.43M
Return on equity
6.00%
Shares outstanding
30.60M
Short % of float
5.99%
50-day average
30.84
200-day average
25.52

Analyst view

Consensus: buy

Buy
Price target (mean) 35.00 +3.9% upside
Target (low)
29.00
Target (mean)
35.00
Target (high)
40.00
Ratings (0m) 6 2 buy · 4 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold4
  • Sell0
  • Strong sell0

Next earnings

Nov 2, 2026

Expected Nov 2, 2026. Consensus EPS estimate 0.145.

Earnings history

Financials — quick view

All financials
HSTM Revenue — quarterly 83.73M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
HSTM Net income — quarterly 6.67M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
HSTM EPS — quarterly 0.23
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

HSTM recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 2, 2026Sep 30, 20260.1583———
Aug 3, 2026Jun 30, 20260.1660.23+0.06+38.55%
May 4, 2026Mar 31, 20260.160.20+0.04+25.00%
Feb 23, 2026Dec 31, 20250.160.09-0.07-43.75%
Nov 3, 2025Sep 30, 20250.170.20+0.03+17.65%
Aug 4, 2025Jun 30, 20250.160.18+0.02+12.50%

Upgrades / downgrades

HSTM analyst upgrades and downgrades
DateFirmActionFromTo
Oct 13, 2026Freedom Capital Marketsinit—Hold
Jul 21, 2026Canaccord GenuitymainHoldHold
May 6, 2026Canaccord GenuitymainHoldHold
Dec 17, 2025Canaccord GenuitymainHoldHold
Aug 7, 2025Canaccord GenuitymainHoldHold
May 15, 2025Canaccord GenuitymainHoldHold

About HealthStream, Inc.

HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company offers hStream, a technology platform; CredentialStream, provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure and other credentials, privileging, appointments by credentialing committees, enrollment, network, management, onboarding, and performance evaluations of providers; ShiftWizard; and Competency Suite, AI/ML-driven clinical competency development system. It also provides applications for performance appraisal, competency management, disclosure management, clinical competency, assessment, development, simulation-based education, clinical rotation and onboarding management, quality management, and industry training. The company's solutions help healthcare organizations in meeting their ongoing learning, clinical development, credentialing, and scheduling needs. It serves the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies, and nursing schools and students. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.

Sector
Healthcare
Industry
Health Information Services
Country
United States

News

Your note

Sign in to keep a note on HSTM — it syncs with the Stock Master app.

Insider holders

HSTM insider holders
InsiderRelationLatest transactionDateShares held
COADY TRISHA LOfficerConversion of Exercise of derivative securitySep 28, 202640,737
COLLIER MICHAEL MANNINGOfficerConversion of Exercise of derivative securitySep 28, 202661,771
CUNNINGHAM JEFFREYChief Technology OfficerConversion of Exercise of derivative securitySep 28, 202638,696
DENT THOMPSON SDirectorConversion of Exercise of derivative securityJun 7, 2026139,975
FRIST ROBERT A JRChief Executive OfficerConversion of Exercise of derivative securitySep 28, 20265,006,850
GORDON FRANK DDirectorConversion of Exercise of derivative securityJun 7, 2026336,356

Institution ownership

HSTM institution ownership
Holder% heldSharesValueReported
Blackrock Inc.13.97%4,080,144137.42MJun 29, 2026
Dimensional Fund Advisors LP5.33%1,557,98152.47MJun 29, 2026
Copeland Capital Management, LLC4.17%1,217,23641.00MSep 29, 2026
Vanguard Capital Management LLC3.58%1,045,29835.21MJun 29, 2026
State Street Corporation3.44%1,004,17033.82MJun 29, 2026
Vanguard Portfolio Management LLC3.01%880,54329.66MJun 29, 2026

Fund ownership

HSTM fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF4.76%1,392,00746.88MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.57%751,13825.30MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.12%618,96720.85MSep 29, 2026
First Eagle Funds-First Eagle Small Cap Opportunity Fund1.84%537,45618.10MJul 30, 2026
DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Targeted Value Portfolio1.02%296,97610.00MJul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund0.92%268,9449.06MJun 29, 2026
Advertisement